Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: Polycythemia vera (PV) is a clonal myeloproliferative neoplasia associated with the activation of the Janus-activating kinase 2 (JAK2) mutation. The aim of this study is to identify clonal expansion of exon 12 mutations. Methods: We performed DNA sequencing of the JAK2 exon 12 after TA-cloning in JAK2 -V617F-negative and JAK2 -V617F-positive PV patients. Results and Conclusions: We found clonal mutations (i.e. H538-K539delinsL and D544G) in 3 of 7 JAK2 -V617F-negative PV patients, however, unlike JAK2 -V617F, allele burden of JAK2 exon 12 mutation was low. Since allele-specific PCR is able to amplify only the limited region which contains known mutations with gain-of-function, we need to clarify the biological implications of unknown single nucleotide substitution of the JAK2 exon 12 with low clonal burden in erythrocytosis patients. © The Author (2009). Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Ohyashiki, J. H., Hisatomi, H., Shimizu, S., Sugaya, M., & Ohyashiki, K. (2009). Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis. Japanese Journal of Clinical Oncology, 39(8), 509–513. https://doi.org/10.1093/jjco/hyp048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free